Homeopathy did not emerge from folk tradition or mystical intuition. It was developed by one of the most rigorous medical minds of the 18th century, tested against the deadliest diseases of the 19th century, and then systematically dismantled in the early 20th – not because it was disproved, but because it was inconvenient. Understanding that history is essential to understanding homeopathy’s place in medicine today.
A physician who refused to accept the medicine of his time
Samuel Christian Hahnemann was born in Meissen, Germany in 1755. By any measure he was an exceptional mind – he was fluent in seven languages before the age of twenty, and trained as a physician at a time when medicine was, by his own blunt assessment, doing patients more harm than good. The standard treatments of the era were brutal: bleeding, purging, large doses of toxic substances like mercury and arsenic. Patients frequently died not of their illness but of their treatment. Hahnemann, gifted with unusual clinical acuity and an uncompromising honesty, stopped practising. He could not in good conscience continue.
He spent several years working as a translator – his languages made him sought-after – and it was during this period that he made the observation that would become the seed of homeopathy. Translating a materia medica by the Scottish physician William Cullen, he encountered an explanation of why cinchona bark (quinine) cured malaria. Cullen attributed it to its bitter, astringent properties. Hahnemann found this unconvincing. He decided to test it on himself.
He took repeated doses of cinchona and observed that he – a healthy person – began to develop symptoms that closely resembled malaria: intermittent fever, chills, joint pain, drowsiness. When he stopped taking the bark, the symptoms resolved. He took it again; the symptoms returned. The implication was striking: the same substance that cured malaria in a sick person produced malaria-like symptoms in a healthy one.
This was not, Hahnemann realised, coincidence. It was a principle. And it was one that had been gestured at – without being systematised – by Hippocrates and Paracelsus before him. He would spend the next several decades developing it into a complete system of medicine.
How Hahnemann built his pharmacopoeia – and what it tells us about his method
Hahnemann was, above all else, a scientist in the deepest sense – not a theorist but an empiricist. He was not satisfied with received wisdom or inherited doctrine. He wanted to know what substances actually did to the human system, observed carefully and recorded precisely.
He developed what he called “provings” – systematic experiments in which healthy volunteers took a substance in small doses over time and kept detailed records of every symptom, sensation, dream, mood change, and physical response they experienced. The resulting symptom picture became the remedy’s profile. When a patient presented with a similar symptom picture, that remedy was indicated.
This method was, by the standards of its era, remarkably rigorous. Hahnemann insisted on careful observation, detailed recording, and the separation of what could be verified from what was merely theoretical. He was also unusual in taking the subjective experience of illness seriously as clinical data – the patient’s own description of their symptoms, their modalities (what made things better or worse), their emotional and mental state. At a time when medicine barely acknowledged the inner life of the patient as medically relevant, this was radical.
It also maps, in ways that become more striking with hindsight, onto something central to the adaptation model described in Part One. The proving process was, in effect, a systematic study of how specific substances perturb the human system – what patterns of response they evoke. And the clinical application was the matching of those perturbation patterns to the patterns of dysfunction that illness had produced. Not treating a disease label, but resonating with a pattern.
Hahnemann called his system “homeopathy” from the Greek: homoios (similar) and pathos (suffering). The name was a deliberate contrast to the “allopathy” – from allos, meaning other – of conventional medicine, which treated by opposition rather than similarity.
Homeopathy meets the great epidemics – and outperforms
Hahnemann published his foundational text, the Organon of Medicine, in 1810. The system spread rapidly through Europe – not through marketing or institutional support, but through results. In an era when epidemic disease was the primary cause of death, and when conventional medicine had little to offer beyond heroic interventions that often weakened already-depleted patients, homeopathy’s gentler approach and its reported outcomes attracted serious attention.
The first major test came with the European cholera pandemics of the 1830s. Cholera killed quickly – death from dehydration and organ failure within hours – and conventional medicine’s mortality rates were catastrophic. Homeopathic hospitals and practitioners reported dramatically lower death rates. In the 1831 cholera epidemic in Europe, mortality in conventionally-treated patients was around 50-60%. Reports from homeopathic practitioners consistently showed mortality rates of 2-20%.
These figures were sufficiently striking that they attracted official notice. The Prussian government investigated and, in 1831, permitted homeopathy to be practised during the epidemic. The Austrian government later compiled statistics that showed homeopathic hospitals significantly outperforming conventional ones across multiple epidemic outbreaks. Whatever the mechanism, something was producing better outcomes.
The 1918 influenza pandemic
The cholera data was not an isolated anomaly. During the 1918 influenza pandemic – the deadliest in recorded history, killing an estimated 50 to 100 million people worldwide – a striking pattern emerged. Conventional medical hospitals reported mortality rates of approximately 30% among their influenza patients. Homeopathic hospitals and practitioners, treating comparable patients, consistently reported mortality rates of 1-2%.
The Journal of the American Institute of Homeopathy published reports in 1921 in which homeopathic physicians described treating thousands of influenza and pneumonia patients with mortality rates far below the national average. Dr. W.A. Pearson of Philadelphia reported collating data on 26,000 cases treated homeopathically with a mortality rate of 1.05%. Conventional hospitals in the same period were recording rates of 25-30%.
These figures remain contested – the methodological standards of the era make direct comparison difficult. But they are too consistent, and too large in magnitude, to be dismissed as noise. We will examine the epidemiological evidence in detail in Part Three.
Homeopathy arrived in the United States in the 1820s and grew rapidly. By the mid-19th century it had become a substantial part of American medical practice, with its own hospitals, medical schools, and professional organisations. At its peak, homeopathy accounted for roughly 15% of all American physicians and operated 22 medical schools, over 100 hospitals, and more than 1,000 pharmacies. It was not fringe. It was mainstream medicine’s most serious competitor.
The AMA, the ethics code, and the campaign to suppress
Homeopathy’s success provoked a response. In 1847 – the same year that homeopathy was at or near the peak of its influence in America – a group of orthodox physicians founded the American Medical Association. The stated purposes were laudable: standardising medical education, improving public health, raising the quality of training. These were genuine needs, and the AMA addressed them. But the founding context included an explicit and sustained hostility toward homeopathy that shaped the organisation’s early character in ways that went well beyond educational reform.
The historical record here is clear, and it is worth stating plainly. The AMA’s early leadership viewed homeopathy not merely as scientifically mistaken but as a competitive threat, and pursued its elimination through institutional means that had little to do with science.
In 1855, just eight years after its founding, the AMA adopted a code of ethics that made it a violation – grounds for expulsion – for any AMA member to consult professionally with a homeopath or any other “irregular” practitioner. This was not a mild guideline. In many states, expulsion from the local medical society meant losing the licence to practise medicine. The code was, in effect, a professional death sentence for any orthodox physician who acknowledged homeopathic colleagues as legitimate.
The enforcement was vigorous. Homeopathic physicians were systematically purged from local medical societies in every state. The exception was Massachusetts, where homeopathy was sufficiently entrenched among Boston’s elite that the AMA permitted its continuation – but only on the condition that no new homeopathic members would be admitted. By 1871, even this exception was closed: the remaining homeopathic members were expelled.
In 1882, the AMA declined to recognise the delegates of the New York State Medical Society – because that society had made the mistake of admitting homeopathic physicians to membership. The message was unmistakable: association with homeopathy in any form was professionally toxic.
Historical context
It would be historically dishonest to present the AMA’s founding purely as an anti-homeopathy campaign. The organisation addressed genuine problems: American medical education in the mid-19th century was genuinely chaotic, with hundreds of schools operating at wildly inconsistent standards. Some of the “irregulars” the AMA opposed were not homeopaths but outright charlatans.
What is also historically clear, however, is that the campaign against homeopathy went well beyond concerns about standards. The 1855 ethics code applied to consulting with any trained homeopath, regardless of their qualifications. The systematic expulsion of homeopathic physicians from medical societies was an act of competitive exclusion, not scientific adjudication. And the eventual near-erasure of homeopathy from American medicine in the early 20th century was achieved primarily through institutional and economic pressure – not through any clinical trial that demonstrated homeopathy’s ineffectiveness.
The Flexner Report and the remaking of American medicine
If the AMA’s 19th-century campaign weakened homeopathy institutionally, the Flexner Report of 1910 came close to finishing the job. Abraham Flexner was an educator – not a physician – commissioned by the Carnegie Foundation to evaluate all medical schools in North America. His report, published in 1910, was genuinely influential in raising the standards of medical education, and that part of its legacy is defensible. Many American medical schools of the era were substandard, and reform was overdue.
But the report’s treatment of homeopathy was neither neutral nor scientifically grounded. Flexner held a strong personal antipathy toward homeopathy and evaluated homeopathic schools not against their clinical outcomes but against their alignment with the German biomedical laboratory model – a model that had not yet proven its superiority in clinical practice, but which was favoured by the institutional and financial interests that funded the review, including the Rockefeller Foundation, which had substantial investments in the emerging pharmaceutical industry.
The consequences were sweeping and rapid. Homeopathic colleges that did not meet the new standards – and the standards were written in ways that made compliance structurally difficult for schools not already oriented toward pharmaceutical medicine – lost accreditation and funding. Schools that had been training competent homeopathic physicians for decades were forced to close. The timeline is stark:
1900 — 22 homeopathic medical schools operating in the United States. Homeopathy represents roughly 15% of American physicians. Over 100 homeopathic hospitals are in operation.
1910 — The Flexner Report is published. Homeopathy, naturopathy, osteopathy, and botanical medicine are systematically derided. Schools not aligned with the pharmaceutical-laboratory model are marked for closure or defunding.
1923 — Only two homeopathic medical schools remain. Within 13 years of the Flexner Report, 20 of the 22 homeopathic schools have closed or converted to allopathic medicine.
1950 — No homeopathic medical colleges remain in the United States. A medical tradition that had operated hospitals, trained physicians, and delivered care to millions had been effectively erased from American institutional medicine within four decades.
It is important to be precise about what this erasure was and was not. It was not the result of clinical trials demonstrating that homeopathy did not work. No such trials had been conducted at sufficient scale or rigour to justify that conclusion. It was the result of a funding and accreditation model that privileged one approach to medicine – the pharmaceutical-laboratory model – and defunded all others. The power shift was institutional and economic, not scientific.
As one historical analysis put it plainly: homeopathy was not disproved. It was outmaneuvered.
What happened in the countries that didn’t follow the American model
The story in the rest of the world unfolded very differently. In Britain, homeopathy was integrated into the National Health Service at its founding in 1948 – in part because of the personal advocacy of King George VI, who was a committed patient. The Royal London Homeopathic Hospital had been operating since 1849 and continued under NHS auspices for decades. (NHS funding for homeopathy was gradually withdrawn between 2017 and 2020 – a development we examine in the limitations section.)
In France, homeopathy became deeply embedded in mainstream medical culture. By the late 20th century, roughly one-third of French GPs were regularly prescribing homeopathic remedies, and homeopathic medicines were reimbursed by the state health insurance system – a status that was only partially reduced in 2021.
In India, the story is most remarkable of all. Homeopathy arrived during the British colonial period and took root with extraordinary tenacity across the subcontinent. Today, India has over 200,000 registered homeopathic practitioners, more than 200 homeopathic medical colleges, and a dedicated government ministry – the Ministry of AYUSH (Ayurveda, Yoga, Unani, Siddha, and Homeopathy) – that funds research, education, and clinical practice. Homeopathy is not alternative medicine in India. It is part of the national health system.
It is in India that the most substantial body of modern clinical research into homeopathy has been conducted – government-funded, peer-reviewed, and increasingly published in international journals. We examine this research in detail in Part Three.
Homeopathy is currently practised in over 80 countries. It is estimated that 500 million people worldwide use homeopathic treatment – making it, by patient numbers, one of the most widely used medical systems on earth. It is integrated into national health systems in India, Brazil, Switzerland, and Mexico, among others. The World Health Organisation has recognised it as one of the most widely practised traditional medicine systems globally.
This does not, of itself, prove efficacy. Widespread use is not the same as demonstrated effectiveness. But it does establish something important: the narrative that homeopathy is a fringe practice sustained only by ignorance is a specifically American and Northern European story, shaped by a specific institutional history. In most of the world, it has never gone away – because millions of patients and tens of thousands of practitioners have continued to find it useful.
A history that matters for how we read the evidence
The history of homeopathy is not just interesting background. It is essential context for evaluating the evidence – and the lack of evidence – that we examine in Part Three.
When critics point to the relative scarcity of high-quality clinical trials for homeopathy compared to pharmaceutical medicine, this is accurate. But the scarcity is not random. It reflects a century of institutional defunding, professional exclusion, and the systematic removal of homeopathy from the research universities and hospitals where clinical science is conducted. A medical tradition that had its educational infrastructure demolished by 1950 and its practitioners excluded from mainstream institutions had neither the funding nor the platform to conduct large-scale clinical research for most of the 20th century.
The research that does exist – and there is considerably more of it than popular commentary acknowledges, much of it from India – needs to be read in this light. We are not assessing a tradition that has been given equal resources and failed to produce evidence. We are assessing one that was deliberately defunded and marginalised, and that has nevertheless produced a body of clinical research that merits serious attention.
